QUICKI Calculator
Free Quickicalculator Calculator with medically-sourced formulas. Enter your measurements for personalized, accurate health insights.
Calculator
Adjust values & calculateFormula
Where Fasting Insulin is in microU/mL and Fasting Glucose is in mg/dL. Higher QUICKI values indicate better insulin sensitivity. Normal is above 0.382, borderline is 0.339-0.382, and below 0.339 indicates insulin resistance. Below 0.30 signifies significant resistance.
Last reviewed: January 2026
Worked Examples
Example 1: Normal Insulin Sensitivity
Example 2: Insulin Resistance Detection
Background & Theory
The QUICKI Calculator applies the following established principles and formulas. Health and medicine calculators are grounded in validated physiological measurement methods established through decades of clinical research. Body Mass Index, or BMI, is calculated by dividing weight in kilograms by height in meters squared (kg/m²), a formula originating from Adolphe Quetelet's 19th-century statistical work and later codified by the WHO into standard classifications: underweight below 18.5, normal weight 18.5 to 24.9, overweight 25 to 29.9, and obese at 30 and above. Basal Metabolic Rate quantifies the minimum energy required to sustain life at rest. The Mifflin-St Jeor equation, published in 1990 and widely regarded as the most accurate for most adults, calculates BMR as (10 × weight in kg) + (6.25 × height in cm) − (5 × age) ± sex adjustment. The older Harris-Benedict equations, revised in 1984 by Roza and Shizgal, remain in common use. Total Daily Energy Expenditure is derived by multiplying BMR by a physical activity factor ranging from 1.2 for sedentary individuals to 1.9 for extremely active ones, following the methodology validated by doubly labeled water studies. Body fat percentage can be estimated without laboratory equipment using the U.S. Navy circumference method, which uses neck, waist, and hip measurements, or via BMI-derived equations adjusted for age and sex. The Jackson-Pollock skinfold method offers higher precision with calipers. Blood pressure classification, according to the American College of Cardiology and the 2017 ACC/AHA guidelines, defines normal as below 120/80 mmHg, elevated as 120 to 129 systolic, and hypertension stage 1 as 130 to 139 systolic or 80 to 89 diastolic. Target heart rate zones for aerobic exercise are derived from maximum heart rate estimates, most commonly using the formula 220 minus age in years, with moderate-intensity training typically defined as 50 to 70 percent of maximum heart rate and vigorous intensity at 70 to 85 percent, consistent with CDC and American Heart Association guidelines. These thresholds guide safe and effective cardiovascular conditioning.
History
The history behind the QUICKI Calculator traces back through the following developments. The history of health measurement stretches back to ancient Greece, where Hippocrates around 400 BCE laid the foundation for observational medicine by systematically recording patient symptoms, diet, and environment. His humoral theory, though scientifically superseded, established the principle that the body operates as an interconnected system subject to measurable imbalance. The transformation toward modern medicine accelerated in the 19th century. Louis Pasteur and Robert Koch developed germ theory in the 1860s and 1870s, identifying microorganisms as disease agents and enabling targeted interventions. Florence Nightingale, working during the Crimean War in the 1850s, introduced statistical analysis to nursing practice, demonstrating through data visualization that sanitation reduced mortality. Her work is foundational to evidence-based health measurement. The discovery of vitamins in the early 20th century, beginning with Casimir Funk's coinage of the term in 1912 and culminating in the isolation of vitamins A through K, created the field of nutritional science and gave rise to dietary reference intake frameworks. The World Health Organization, founded in 1948, subsequently established global standards for health metrics, disease classification through the International Classification of Diseases, and recommended daily allowances. The BMI as a clinical screening tool gained traction in the 1970s through Ancel Keys' large-scale epidemiological work, which validated Quetelet's index as a population-level obesity indicator. Through the 1980s and 1990s, the Framingham Heart Study produced landmark data linking cholesterol, blood pressure, and lifestyle factors to cardiovascular disease risk, directly shaping the numeric thresholds still used in health calculators. The evidence-based medicine movement, formalized by Gordon Guyatt and colleagues at McMaster University in the early 1990s, demanded that all health recommendations derive from systematically graded clinical evidence. The digital health era beginning in the 2000s brought these formulas to consumer devices, wearable sensors, and smartphone applications, expanding access to health self-monitoring on a global scale and enabling population-level data collection that continues to refine clinical reference ranges.
Frequently Asked Questions
Formula
QUICKI = 1 / (log10(Fasting Insulin) + log10(Fasting Glucose))
Where Fasting Insulin is in microU/mL and Fasting Glucose is in mg/dL. Higher QUICKI values indicate better insulin sensitivity. Normal is above 0.382, borderline is 0.339-0.382, and below 0.339 indicates insulin resistance. Below 0.30 signifies significant resistance.
Worked Examples
Example 1: Normal Insulin Sensitivity
Problem: Calculate QUICKI for a patient with fasting glucose of 85 mg/dL and fasting insulin of 5 microU/mL.
Solution: QUICKI = 1 / (log10(5) + log10(85))\nQUICKI = 1 / (0.6990 + 1.9294)\nQUICKI = 1 / 2.6284\nQUICKI = 0.3805\nHOMA-IR = (4.72 x 5) / 22.5 = 1.05\nThis indicates borderline-normal insulin sensitivity
Result: QUICKI = 0.3805 (Borderline Normal) | HOMA-IR = 1.05 | Good sensitivity
Example 2: Insulin Resistance Detection
Problem: Calculate QUICKI for a patient with fasting glucose of 120 mg/dL and fasting insulin of 25 microU/mL.
Solution: QUICKI = 1 / (log10(25) + log10(120))\nQUICKI = 1 / (1.3979 + 2.0792)\nQUICKI = 1 / 3.4771\nQUICKI = 0.2876\nHOMA-IR = (6.66 x 25) / 22.5 = 7.40\nSignificant insulin resistance detected
Result: QUICKI = 0.2876 (Low) | HOMA-IR = 7.40 | Significant insulin resistance
Frequently Asked Questions
What is the QUICKI index and how does it measure insulin sensitivity?
QUICKI stands for Quantitative Insulin Sensitivity Check Index. It is a mathematical formula that estimates insulin sensitivity using fasting glucose and fasting insulin levels from a single blood draw. Developed by Katz et al. in 2000, QUICKI uses a logarithmic transformation to linearize the relationship between insulin and glucose, providing a more normally distributed measure compared to HOMA-IR. The formula is QUICKI = 1 / (log10 fasting insulin + log10 fasting glucose). Higher QUICKI values indicate better insulin sensitivity, with normal values typically above 0.382. QUICKI has been validated against the gold standard euglycemic-hyperinsulinemic clamp and shows correlation coefficients of 0.78-0.89, making it one of the most accurate surrogate measures available.
How is QUICKI calculated and what do the numbers mean?
QUICKI is calculated as the inverse of the sum of the base-10 logarithms of fasting insulin (in microU/mL) and fasting glucose (in mg/dL). The logarithmic transformation is key because the relationship between insulin and glucose is nonlinear, and log transformation produces a more linear and normally distributed output. Normal QUICKI values range from 0.382 to 0.450, with higher values indicating greater insulin sensitivity. Values between 0.339 and 0.382 suggest borderline insulin sensitivity. Values below 0.339 indicate insulin resistance, and values below 0.30 suggest significant insulin resistance associated with metabolic syndrome. Unlike HOMA-IR where higher values indicate worse outcomes, higher QUICKI values indicate better insulin sensitivity.
How does QUICKI compare to HOMA-IR for measuring insulin resistance?
QUICKI and HOMA-IR are mathematically related but use different transformations. HOMA-IR multiplies glucose by insulin and divides by a constant, while QUICKI uses logarithmic transformation. Several comparative studies have shown that QUICKI correlates more closely with clamp-derived insulin sensitivity than HOMA-IR, particularly in obese individuals and those with significantly impaired insulin sensitivity. The logarithmic transformation in QUICKI better captures the nonlinear relationship between insulin and glucose at extreme values. However, both measures use the same input data (fasting glucose and insulin), so they are highly correlated with each other. Many researchers report both values for completeness. QUICKI is particularly favored in research settings due to its better statistical properties and normal distribution.
What factors can affect QUICKI results and how can accuracy be improved?
Several factors affect QUICKI accuracy. The most important is proper fasting: patients must fast for 8-12 hours, and samples should be drawn in the morning between 7-10 AM to minimize circadian variation. Stress, poor sleep, and acute illness can elevate cortisol and catecholamines, affecting both glucose and insulin levels. Certain medications including steroids, beta-blockers, thiazide diuretics, and atypical antipsychotics can alter insulin sensitivity and should be noted when interpreting results. Hemolysis of the blood sample can falsely lower insulin measurements. For maximum reliability, consider averaging results from two or three separate fasting blood draws taken on different days. The coefficient of variation for QUICKI is approximately 10-15%, meaning small changes between measurements may not be clinically significant.
Can QUICKI be used to monitor treatment response over time?
QUICKI is an excellent tool for monitoring treatment response because it is sensitive to changes in insulin sensitivity induced by interventions. Weight loss studies have shown that QUICKI values increase by 0.02-0.05 points with 5-10% body weight reduction, reflecting improved insulin sensitivity. Exercise interventions typically improve QUICKI by 0.01-0.03 points within 8-12 weeks. Metformin treatment can increase QUICKI by 0.02-0.04 points, while thiazolidinediones may improve it by 0.03-0.06 points. When monitoring treatment response, consistent testing conditions are critical for comparing values over time. A clinically meaningful change in QUICKI is generally considered to be at least 0.02 points, given the inherent biological variability.
What is the revised QUICKI and how does it differ from standard QUICKI?
The revised QUICKI (rQUICKI) adds a third variable, fasting free fatty acids (FFA), to the standard formula: rQUICKI = 1 / (log10 insulin + log10 glucose + log10 FFA). The inclusion of free fatty acids improves the accuracy of insulin sensitivity estimation because FFAs play a critical role in insulin resistance through lipotoxicity and impaired insulin signaling pathways. Studies have shown that rQUICKI correlates even more strongly with clamp-derived insulin sensitivity than standard QUICKI, particularly in obese individuals and those with non-alcoholic fatty liver disease. However, rQUICKI requires an additional lab measurement that is not routinely available, limiting its practical application in clinical settings compared to the standard QUICKI formula.
References
Reviewed by Rahul Singh, Health & Wellness Specialist · Editorial policy